Bulk Pharmaceutical API Sources for ULIPRISTAL ACETATE

Bulk Pharmaceutical API Sources for ULIPRISTAL ACETATE

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		130904
ABI Chem		AC1L2Y8A
AK Scientific, Inc. (AKSCI)		X4788
MedChemexpress MCE		HY-16508
AbaChemScene		CS-1157

Bulk Active Pharmaceutical Ingredient (API) Sources for: Ulipristal Acetate

Last updated: July 30, 2025

Introduction

Ulipristal acetate is a selective progesterone receptor modulator primarily used for emergency contraception and the treatment of uterine fibroids. As a critical component in these indications, the quality, availability, and sourcing of its active pharmaceutical ingredient (API) directly influence manufacturing, regulatory compliance, and supply chain stability. This article examines the leading API manufacturers, sourcing trends, and strategic considerations relevant to stakeholders engaged in ulipristal acetate procurement and supply chain management.

Overview of Ulipristal Acetate

Ulipristal acetate's chemical structure (C30H23ClF3N2O2S) enables its role as a selective progesterone receptor modulator, combining both antagonistic and partial agonist activities in estrogen-dependent tissues. Its regulatory approval in multiple markets—particularly in the European Union, the United States, and Asia—has driven global demand, necessitating robust sourcing routes from reputable API producers.

Major API Suppliers and Manufacturers

1. European Producers

HRA Pharma / Gedeon Richter:
HRA Pharma, now part of Gedeon Richter, pioneered ulipristal acetate synthesis. Their manufacturing facilities in Europe, particularly Hungary, produce high-quality API for their own formulations and licensed partnerships across Europe. Known for stringent GMP standards, their APIs meet international quality benchmarks.

Dr. Reddy's Laboratories (India):
While primarily known for generics, Dr. Reddy's has expanded its API portfolio to include ulipristal acetate, sourced from partnerships with European manufacturers or through their own facilities. Their global footprint and GMP compliance make them a significant supplier.

2. Asian API Manufacturers

Zhejiang Hisun Pharmaceutical Co., Ltd.:
Based in China, Hisun has invested in high-quality API manufacturing, including complex molecules like ulipristal acetate. Their capacity expansion aligns with global regulatory expectations, making them notable in Asia-Pacific supply chains.

Cipla Limited (India):
Cipla, a prominent Indian pharmaceutical exporter, announced capabilities to produce APIs for hormonal modulators, including ulipristal acetate. Their extensive network supports large-volume API supplies for both domestic and export markets.

Shandong Xinhua Pharmaceutical:
Another Chinese manufacturer with capabilities in steroid and hormonal APIs, Xinhua has made strategic investments in advanced synthesis processes, potentially covering ulipristal acetate.

3. Contract Manufacturing Organizations (CMOs)

Several CMOs globally specialize in advanced APIs, including ulipristal acetate. Notably:

• Boehringer Ingelheim: Offers custom synthesis services for complex APIs following regulatory standards, possibly providing domestically or through licensing agreements.

• Thermo Fisher Scientific: Provides custom manufacturing for a range of APIs, often supporting supply chain gaps in niche pharmaceuticals.

• Nucleus Biotech: Known for entry into hormonal API synthesis, with capacity for long-term supply agreements.

Sourcing Considerations

Quality Assurance and Regulatory Compliance

Selecting an API source for ulipristal acetate mandates rigorous quality standards. Manufacturers must comply with Good Manufacturing Practices (GMP) stipulated by agencies like the EMA, FDA, or PMDA. Third-party audits, stability data, and dossiers are critical in validating raw material integrity and batch-to-batch consistency.

Supply Chain Stability

The complexity of synthesizing ulipristal acetate—with multiple stereoselective steps—makes supply chain resilience vital. Geographic diversification, multi-supplier agreements, and inventory buffers mitigate risks associated with regional disruptions, geopolitical tensions, or regulatory delays.

Pricing and Contractual Terms

Pricing varies widely depending on the manufacturer, capacity, and regulatory status. Large-scale manufacturers often provide competitive pricing but may entail longer lead times due to capacity constraints. Conversely, emerging regional suppliers may offer nimble delivery but at premium costs or with varying quality assurance track records.

Emerging Trends in API Sourcing

Localization and Nearshoring

Driven by global supply chain disruptions, pharma companies increasingly prioritize local or regional API suppliers. In Europe and North America, partnerships with European manufacturers or advanced CMOs aim to secure supply chains for ulipristal acetate, especially given its critical role in emergency contraception.

Enhanced Regulatory Oversight and Post-Approval Changes

Enhanced regulatory scrutiny necessitates meticulous documentation and traceability. Sourcing from trusted suppliers with a history of compliance expedites approval processes and reduces the risk of regulatory sanctions.

Sustainable and Responsible Sourcing

Environmental, social, and governance (ESG) factors influence supply decisions. Manufacturers adopting sustainable practices, transparent sourcing, and responsible manufacturing are favored, aligning with industry expectations and regulatory trends.

Regulatory Landscape Influencing API Sourcing

Regulatory agencies emphasize API quality for drug safety and efficacy. The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) maintain strict standards, often requiring API manufacturers to list in the European Directorate for the Quality of Medicines & HealthCare (EDQM) or FDA onsite inspections. Importer companies must ensure their sources' certifications and batch documentation are compliant with local regulations to facilitate registration and approvals.

Key Challenges in API Sourcing

• Supply Disruptions: Global crises, trade restrictions, or manufacturing bottlenecks can jeopardize supply continuity.
• Quality Variability: Non-compliant manufacturing affects product safety and regulatory approval.
• Pricing Volatility: Fluctuations in raw material costs or manufacturing capacity constraints impact API prices.
• Intellectual Property (IP): Sourcing from authorized producers ensures patent compliance and avoids legal complications.

Conclusion

The landscape of ulipristal acetate API sourcing is dynamic and complex, influenced by manufacturing capabilities, regulatory compliance, geopolitical considerations, and market demand. Leading European and Asian manufacturers, complemented by specialized CMOs, comprise the primary sources. Stakeholders must prioritize quality, supply chain resilience, and regulatory alignment when selecting API suppliers to ensure the consistent production of high-quality formulations.

---

Key Takeaways

• Leading API supplies for ulipristal acetate include European manufacturers such as Gedeon Richter and Asian firms like Zhejiang Hisun and Cipla.
• Regulatory compliance with GMP and international quality standards is essential for sourcing credible APIs.
• Geographical diversification and strategic partnerships mitigate supply risks amidst global disruptions.
• Emerging trends favor regional sourcing, sustainable practices, and robust regulatory oversight.
• Thorough supplier due diligence and quality validation streamline approvals and ensure product safety.

---

FAQs

1. What are the primary regions supplying ulipristal acetate API?
Europe and Asia are the main regions, with leading manufacturers based in the European Union (e.g., Gedeon Richter) and China or India (e.g., Zhejiang Hisun, Cipla).

2. How can manufacturers ensure API quality and regulatory compliance?
By sourcing from GMP-certified suppliers, conducting comprehensive audits, reviewing batch documentation, and maintaining rigorous quality control processes.

3. What are the risks associated with sourcing ulipristal acetate API from emerging manufacturers?
Risks include variable quality standards, regulatory uncertainties, and potential supply chain disruptions, emphasizing the importance of due diligence.

4. How does geopolitical activity impact API sourcing for ulipristal acetate?
Trade restrictions, tariffs, and regional conflicts can limit access, prompting companies to seek diversified and localized sources.

5. What role do CMOs play in the ulipristal acetate API supply chain?
CMOs offer custom synthesis, capacity scalability, and flexibility, often enabling rapid response to supply needs while maintaining compliance.

---

References

[1] European Medicines Agency. "Ulipristal acetate: Summary."
[2] Gedeon Richter Group. "API manufacturing capabilities."
[3] World Health Organization. "Good manufacturing practices for pharmaceutical substances."
[4] Indian Pharmacopoeia Commission. "API quality standards."
[5] Pharmaceutical Technology. "The impact of API sourcing on drug manufacturing."